Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Multiple Sclerosis and Related Disorders
|
January 10, 2026
Binaural hearing, neurological disability and brain imaging in Multiple Sclerosis
Gary Rance, Julien Zanin, Daniel Merlo, et al.
Therapeutic Advances in Neurological Disorders
|
July 20, 2019
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis
Daniel Merlo, David Darby, Tomas Kalincik, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 25, 2011
Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions
Jennifer K Sabo, Tim D Aumann, Daniel Merlo, et al.
Multiple Sclerosis and Related Disorders
|
September 8, 2023
Managing cognitive impairment and its impact in multiple sclerosis: An Australian multidisciplinary perspective
Jeannette Lechner-Scott, Susan Agland, Michelle Allan, et al.
Multiple Sclerosis and Related Disorders
|
March 31, 2023
Smartphone monitoring of cognition in people with multiple sclerosis: A systematic review
Yi Chao Foong, Francesca Bridge, Daniel Merlo, et al.
Neuroscience Letters
|
August 3, 2010
Influence of methylprednisolone on magnetic resonance and histological measures during cuprizone-induced demyelination
Holly S Cate, Qi-Zhu Wu, Dennis Kemper, et al.
Multiple Sclerosis and Related Disorders
|
February 27, 2026
Chronic lesion expansion as an imaging biomarker in multiple sclerosis
Michael T G Hayes, Heidi N Beadnall, Daniel Merlo, et al.
Eneuro
|
April 28, 2019
Inhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte Differentiation
Alistair E Govier-Cole, Rhiannon J Wood, Jessica L Fletcher, et al.
Journal of Cellular Physiology
|
May 24, 2011
Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor fasudil reveals cytoskeletal and pro-survival responses
Chew L Lau, Victoria M Perreau, Minghui J Chen, et al.
Journal of Neurochemistry
|
March 3, 2010
Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination
Holly S Cate, Jennifer K Sabo, Daniel Merlo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Multiple Sclerosis and Related Disorders
|
January 10, 2026
Binaural hearing, neurological disability and brain imaging in Multiple Sclerosis
Gary Rance, Julien Zanin, Daniel Merlo, et al.
Therapeutic Advances in Neurological Disorders
|
July 20, 2019
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis
Daniel Merlo, David Darby, Tomas Kalincik, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 25, 2011
Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions
Jennifer K Sabo, Tim D Aumann, Daniel Merlo, et al.
Multiple Sclerosis and Related Disorders
|
September 8, 2023
Managing cognitive impairment and its impact in multiple sclerosis: An Australian multidisciplinary perspective
Jeannette Lechner-Scott, Susan Agland, Michelle Allan, et al.
Multiple Sclerosis and Related Disorders
|
March 31, 2023
Smartphone monitoring of cognition in people with multiple sclerosis: A systematic review
Yi Chao Foong, Francesca Bridge, Daniel Merlo, et al.
Neuroscience Letters
|
August 3, 2010
Influence of methylprednisolone on magnetic resonance and histological measures during cuprizone-induced demyelination
Holly S Cate, Qi-Zhu Wu, Dennis Kemper, et al.
Multiple Sclerosis and Related Disorders
|
February 27, 2026
Chronic lesion expansion as an imaging biomarker in multiple sclerosis
Michael T G Hayes, Heidi N Beadnall, Daniel Merlo, et al.
Eneuro
|
April 28, 2019
Inhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte Differentiation
Alistair E Govier-Cole, Rhiannon J Wood, Jessica L Fletcher, et al.
Journal of Cellular Physiology
|
May 24, 2011
Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor fasudil reveals cytoskeletal and pro-survival responses
Chew L Lau, Victoria M Perreau, Minghui J Chen, et al.
Journal of Neurochemistry
|
March 3, 2010
Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination
Holly S Cate, Jennifer K Sabo, Daniel Merlo, et al.
Page
of 3